ERBB2 and esophageal cancer: In recent years, many differential gene expression changes in esophageal cancer are related to the pathological mechanism, treatment, and prognosis of the disease; however, the treatment and prognosis improvement of esophageal cancer for known targets like EGFR and HER-2 are still insufficient.